Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Total 13F shares
-
22,046,847
-
Share change
-
+3,148,632
-
Total reported value
-
$386,593,075
-
Price per share
-
$17.53
-
Number of holders
-
43
-
Value change
-
+$58,495,806
-
Number of buys
-
21
-
Number of sells
-
16
Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q4 2020
As of 31 Dec 2020,
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,046,847 shares.
The largest 10 holders included
BVF INC/IL, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, Medicxi Ventures Management (Jersey) Ltd, BOXER CAPITAL, LLC, Sofinnova Investments, Inc., WELLINGTON MANAGEMENT GROUP LLP, DRIEHAUS CAPITAL MANAGEMENT LLC, MPM ONCOLOGY IMPACT MANAGEMENT, L.P., and MPM Oncology Impact Management LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.